Rafael Holdings, Inc.
corporate_fare Company Profile
Rafael Holdings, Inc. (NYSE:RFL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for RFL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for RFL spans DEF 14A, 10-K, 8-K, 10-Q.
Recent high-impact activity:
- Rafael Proxy Seeks 2.42M More Plan Shares to Enable 1.93M Options Tied to FDA Approval
- Rafael Holdings 10-K: Going-Concern Warning With $22.1M Cash After $29.6M FY2026 Loss
- Rafael Holdings Posts $29.6M FY2026 Loss, $22.1M Cash, Confirms NDA Filing
- Rafael Files FDA NDA for NPC Drug Despite Phase 3 Miss
- Trappsol Cyclo Misses Phase 3 Primary Endpoint but Shows Survival Benefit
Financial Snapshot
Short Interest & Short Volume
5.19 days to coverFINRA reported short interest of 292,865 shares in RFL as of the October 30, 2026 settlement, a 15.9% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 66.1% of RFL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.